Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty

FASEB J. 2005 Feb;19(2):246-8. doi: 10.1096/fj.04-2431fje. Epub 2004 Nov 16.


Rapamycin combines antiproliferative and antiinflammatory properties and reduces neointima formation after angioplasty in patients. Its effect on transcriptional programs governing neointima formation has not yet been investigated. Here, we systematically analyzed the effect of rapamycin on gene expression during neointima formation in a human organ culture model. After angioplasty, renal artery segments were cultured for 21 or 56 days in absence or presence of 100 ng/ml rapamycin. Gene expression analysis of 2312 genes revealed 264 regulated genes with a peak alteration after 21 days. Many of those were associated with recruitment of blood cells and inflammatory reactions of the vessel wall. Likewise, chemokines and cytokines such as M-CSF, IL-1beta, IL-8, beta-thromboglobulin, and EMAP-II were found up-regulated in response to vessel injury. Markers indicative for a facilitated recruitment and stimulation of hematopoetic progenitor cells (HPC), including BST-1 and SDF-1, were also induced. In this setting, rapamycin suppressed the coordinated proadhesive and proinflammatory gene expression pattern next to down-regulation of genes related to metabolism, proliferation, and apoptosis. Our study shows that mechanical injury leads to induction of a proinflammatory, proadhesive gene expression pattern in the vessel wall even in absence of leukocytes. These molecular events could provide a basis for the recruitment of leukocytes and HPC. By inhibiting the expression of such genes, rapamycin may lead to a reduced recruitment of leukocytes and HPC after vascular injury, an effect that may play a decisive role for its effectiveness in reducing restenosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Aged
  • Angioplasty, Balloon / adverse effects*
  • Apoptosis / genetics
  • Cell Proliferation / drug effects
  • Cluster Analysis
  • Down-Regulation / drug effects
  • Endothelium, Vascular / chemistry
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Extracellular Matrix / genetics
  • Female
  • Gene Expression Profiling / methods
  • Gene Expression Profiling / statistics & numerical data
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Graft Occlusion, Vascular / genetics
  • Graft Occlusion, Vascular / pathology
  • Graft Occlusion, Vascular / prevention & control
  • Humans
  • Immunohistochemistry / methods
  • Inflammation / genetics
  • Inflammation / prevention & control
  • Male
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / genetics
  • Oligonucleotide Array Sequence Analysis / methods
  • Oligonucleotide Array Sequence Analysis / statistics & numerical data
  • Organ Culture Techniques / methods
  • Renal Artery / chemistry
  • Renal Artery / drug effects*
  • Renal Artery / metabolism
  • Renal Artery / pathology*
  • Sirolimus / pharmacology*
  • Sirolimus / therapeutic use
  • Stem Cells
  • Stents
  • Time
  • Tissue Adhesions / genetics
  • Transcription, Genetic / drug effects
  • Transcription, Genetic / genetics
  • Tunica Intima / metabolism
  • beta-Thromboglobulin / biosynthesis
  • beta-Thromboglobulin / immunology


  • beta-Thromboglobulin
  • Sirolimus